Key result
Whole-exome sequencing identifies a novel deep intronic FBN1 variant causing Marfan syndrome via exon skipping.
Why the study?
Molecular diagnosis remains challenging for 8%-10% of patients with clinical features suggestive of Marfan syndrome despite known pathogenic FBN1 variants.
Case Report (n=1)
No
The study expands the mutation spectrum of FBN1 by identifying and functionally validating a novel deep intronic variant causing Marfan syndrome, highlighting the importance of evaluating non-coding regions in genetically unexplained cases.
May warrant intronic analysis in unresolved Marfan cases; leaves open prevalence and validation in larger cohorts.
Marfan syndrome (MFS MIM#154700), due to pathogenic variants in the FBN1 gene, is an autosomal dominant connective tissue disorder, typically involving the skeletal, cardiovascular and ocular systems. Currently, over 3000 MFS patients were reported, and approximately 1800 pathogenic variants in FBN1 were identified. However, the molecular diagnosis still remains challenging for 8%–10% of patients with clinical features suggestive of MFS. In this study, we reported a 2-month-old Chinese female patient whose clinical features were compatible with the MFS. Whole-exome sequencing (WES) identified a novel de novo deep intronic variant, c.4943-8_4943-7insTATGTGATATTCAT TCAC in intron 40 of FBN1 that was predicted to affect the RNA splicing. Minigene analysis showed that this variant causes skipping of exon 41, leading to the deletion of 41 amino acids (c.4943_5065del, p.Val1649_Asp1689del). It confirmed the pathogenic nature of the variant and established the genotype-phenotype relationship. Our study expands the mutation spectrum of FBN1 and emphasizes the importance of deep intronic variant interpretation and the need for additional functional studies to verify the pathogenicity of these variants.
No takes yet. Share an insight, caveat, or question.
Wang et al. (2025) conducted a case report in Marfan syndrome (n=1). Whole-exome sequencing and minigene analysis was evaluated on Identification and functional validation of genetic variant. Whole-exome sequencing and minigene analysis identified a novel de novo deep intronic variant in FBN1 (c.4943-8_4943-7insTATGTGATATTCATTCAC) causing exon 41 skipping in a patient with Marfan syndrome.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: